Content area
Full text
About the Authors:
Viraj Kulkarni
Affiliation: Human Retrovirus Pathogenesis Section, Vaccine Branch, Center for Cancer Research, National Cancer Institute, Frederick, Maryland, United States of America
Antonio Valentin
Affiliation: Human Retrovirus Section, Vaccine Branch, Center for Cancer Research, National Cancer Institute, Frederick, Maryland, United States of America
Margherita Rosati
Affiliation: Human Retrovirus Section, Vaccine Branch, Center for Cancer Research, National Cancer Institute, Frederick, Maryland, United States of America
Candido Alicea
Affiliation: Human Retrovirus Pathogenesis Section, Vaccine Branch, Center for Cancer Research, National Cancer Institute, Frederick, Maryland, United States of America
Ashish K. Singh
Affiliation: Human Retrovirus Section, Vaccine Branch, Center for Cancer Research, National Cancer Institute, Frederick, Maryland, United States of America
Rashmi Jalah
Affiliation: Human Retrovirus Pathogenesis Section, Vaccine Branch, Center for Cancer Research, National Cancer Institute, Frederick, Maryland, United States of America
Kate E. Broderick
Affiliation: Inovio Pharmaceuticals, Inc., Blue Bell, Pennsylvania, United States of America
Niranjan Y. Sardesai
Affiliation: Inovio Pharmaceuticals, Inc., Blue Bell, Pennsylvania, United States of America
Sylvie Le Gall
Affiliation: Ragon Institute of MGH, MIT and Harvard, Boston, Massachusetts, United States of America
Beatriz Mothe
Affiliation: IrsiCaixa AIDS Research Institute-HIVACAT, Autonomous University of Barcelona, Barcelona, Spain
Christian Brander
Affiliations IrsiCaixa AIDS Research Institute-HIVACAT, Autonomous University of Barcelona, Barcelona, Spain, Institucio Catalana de Recerca i Estudis Avancats (ICREA), Barcelona, Spain
Morgane Rolland
Current address: Military HIV Research Program, Rockville, Maryland, United States of America
Affiliation: Department of Microbiology, University of Washington, Seattle, Washington, United States of America
James I. Mullins
Affiliations Department of Microbiology, University of Washington, Seattle, Washington, United States of America, Department of Medicine, University of Washington, Seattle, Washington, United States of America, Department of Laboratory Medicine, University of Washington, Seattle, Washington, United States of America
George N. Pavlakis
* E-mail: [email protected] (GNP); [email protected] (BKF)
Affiliation: Human Retrovirus Section, Vaccine Branch, Center for Cancer Research, National Cancer Institute, Frederick, Maryland, United States of America
Barbara K. Felber
* E-mail: [email protected] (GNP); [email protected] (BKF)
Affiliation: Human Retrovirus Pathogenesis Section, Vaccine Branch, Center for Cancer Research, National Cancer Institute, Frederick, Maryland, United States of America
Introduction
An ideal HIV vaccine should provide protection against all HIV-1 variants. Yet, HIV-1 is so variable that it may escape immunity provided by the vaccine candidates evaluated to date, due to intrasubtype or even intrahost...